Male Infertility Drugs Pipeline Review H1 2017 guide reviews of key players involved in therapeutic development for Male Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 2, 5, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively. Male Infertility Pipeline Review H1 2017 provides comprehensive information on the therapeutics under development for Male Infertility (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Get Discount on This Report at http://www.reportsnreports.com/contacts/discount.aspx?name=944641 .
Companies involved in Male Infertility therapeutics development analysed in report are
AlphaMab Co Ltd, Ferring International Center SA, Health Ever Bio-Tech Co Ltd, Navya Biologicals Pvt Ltd, PharmaEssentia Corp, TocopheRx Inc, Zydus Cadila Healthcare Ltd.
Male Infertility (Male Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Purchase This Report at http://www.reportsnreports.com/purchase.aspx?name=944641
Male Infertility Drug Profiles Discussed In Report are Biosimilar 2 for Diabetes, Infertility and Rheumatoid Arthritis, Biosimilar 5 for Infertility and Oncology, Biosimilar 6 for Infertility, Oncology and Immunology, Biosimilar 7 for Infertility, Immunology, Infectious Disease and Oncology, FE-999310, LM-002, MCS-5, NAV-013, PEG-FSH, Recombinant Beta Glucosidase 2 Replacement for Gaucher’s Disease and Male Infertility, TOP-001, TOP-002, trequinsin.
- The pipeline guide provides a snapshot of the global therapeutic landscape of Male Infertility (Male Health).
- The pipeline guide reviews pipeline therapeutics for Male Infertility (Male Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Male Infertility (Male Health) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Male Infertility (Male Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
List of Tables
- Number of Products under Development for Male Infertility, H1 2017
- Number of Products under Development by Companies, H1 2017
- Number of Products under Development by Universities/Institutes, H1 2017
- Products under Development by Companies, H1 2017
- Products under Development by Universities/Institutes, H1 2017
- Number of Products by Stage and Target, H1 2017
- Number of Products by Stage and Mechanism of Action, H1 2017
- Number of Products by Stage and Route of Administration, H1 2017
- Number of Products by Stage and Molecule Type, H1 2017
- Male Infertility Pipeline by AlphaMab Co Ltd, H1 2017
- Male Infertility Pipeline by Ferring International Center SA, H1 2017
- Male Infertility Pipeline by Health Ever Bio-Tech Co Ltd, H1 2017
- Male Infertility Pipeline by Navya Biologicals Pvt Ltd, H1 2017
- Male Infertility Pipeline by PharmaEssentia Corp, H1 2017
- Male Infertility Pipeline by TocopheRx Inc, H1 2017
- Male Infertility Pipeline by Zydus Cadila Healthcare Ltd, H1 2017
- Male Infertility Dormant Projects, H1 2017
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441